July 22, 2019
For the first time, social media last year surpassed newspapers as a news source in the U.S. Nine in 10 Americans say they get at least some of their news digitally, and by the end...Read More
June 11, 2019
A multicenter research team led jointly by UNC and Washington University School of Medicine in St. Louis has received a five-year, $9.5 million grant to further evaluate whether brain imaging can help detect very high...Read More
UNC researchers will use an $11.3 million grant to explore using nanoparticles to create cancer vaccines and improve delivery of cancer-fighting drugs and patients’ responses to them.
The five-year grant announced Monday is the third in a series of awards that the University has won from the National Cancer Institute for cancer nanotechnology research. It will fund researchers with the Carolina Center of Cancer Nanotechnology Excellence, an institute-funded collaboration between the University and the UNC Lineberger Comprehensive Cancer Center.
“UNC-Chapel Hill has emerged as a leader in nanotechnology in the last 10 years,” said Leaf Huang, a UNC Lineberger member, Fred Eshelman Distinguished Professor and interim chair of the UNC Eshelman School of Pharmacy Division of Molecular Therapeutics, and the co-leader of the cancer nanotechnology center. “This grant is a testament to the quality of our research in using nanotechnology to continue to find innovative ways to fight cancer.”
The grant will fund four studies of nanotechnology in fighting cancer: